REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ceva-Phylaxia Zrt. (Hungary)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Ceva-Phylaxia Zrt. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

Ceva-Phylaxia operates as a veterinary pharmaceutical company specializing in the research, development, manufacturing and distribution of animal health products. The portfolio includes vaccines, pharmaceuticals and biological products for livestock and companion animals. Operations include production facilities and R&D capabilities in Hungary, serving domestic and international markets. Strategic focus emphasizes animal health innovation, biosecurity and integration into global veterinary healthcare value chains.

Headquarters
Szallas u. 5.
Budapest; Budapest; Postal Code: 1107

Contact Details: Purchase the Ceva-Phylaxia Zrt. report to view the information.

Website: http://www.ceva.hu

Basic Information
Total Employees:
Purchase the Ceva-Phylaxia Zrt. report to view the information.
Registered Capital:
Purchase the Ceva-Phylaxia Zrt. report to view the information.
Financial Auditors:
Purchase the Ceva-Phylaxia Zrt. report to view the information.
Incorporation Date:
June 14, 1991
Key Executives
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Ceva-Phylaxia Zrt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
26.85%▲
Total operating revenue
23.86%▲
Operating profit (EBIT)
N/A
EBITDA
656.92%▲
Net Profit (Loss) for the Period
-77.54%▼
Total Assets
22.78%▲
Total Equity
-31.79%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-2.27%▼
Return on Equity (ROE)
-28.26%▼
Quick Ratio
-0.25%▼
Cash Ratio
0.04%▲

Similar companies

Richter Gedeon Nyrt.
 
PHOENIX Pharma Zrt.
Egis Gyogyszergyar Zrt.
 
Teva Gyogyszergyar Zrt.
CHINOIN Zrt.
 
Novartis Hungaria Kft.
Alkaloida Vegyeszeti Gyar Zrt.
 
Beres Gyogyszergyar Zrt.
Glaxosmithkline Biologicals Kft.
 
Plazmaszolgalat Kft.
XELLIA Kft.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo